These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19024490)

  • 1. [Elevated PSA--what to do?].
    Machemer H; Rohde D
    MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic work-up of the prostate carcinoma].
    Breul J; Paul R
    MMW Fortschr Med; 2006 Nov; 148(44):26-8, 30. PubMed ID: 17619436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of prostate cancer].
    Seitz M; Stanislaus P; Stief C
    MMW Fortschr Med; 2008 Jul; 150(28-31):39-41, 43. PubMed ID: 19006891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of prostate cancer].
    Strittmatter F
    MMW Fortschr Med; 2010 May; 152(19):40-2. PubMed ID: 20557001
    [No Abstract]   [Full Text] [Related]  

  • 5. PSA screening: the bottom line.
    Elhilali MM
    CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer: screening and early detection.
    Tariman JD
    Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
    Bastian PJ; Stief CG
    MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
    [No Abstract]   [Full Text] [Related]  

  • 8. [PSA screening--medically useful or superfluous?].
    Glatz U
    Dtsch Med Wochenschr; 2010 Jan; 135(4):p3. PubMed ID: 20101552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H; Pedersen KV
    Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The assessment of pathological PSA values by the general practitioner--observation or intervention?].
    Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V
    Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
    Zhao XJ; Kong XB; Wang WH
    Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
    Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
    Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.
    Greiver M; Rosen N
    CMAJ; 2000 Mar; 162(6):789-90. PubMed ID: 10750465
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign positive margins after radical prostatectomy means a poor prognosis--pro.
    Djavan B; Milani S; Fong YK
    Urology; 2005 Feb; 65(2):218-20. PubMed ID: 15708025
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA and prostate cancer screening: the challenge of the new millennium.
    Bjartell A
    Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
    [No Abstract]   [Full Text] [Related]  

  • 17. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PSA follow-up after radical prostatectomy].
    Egawa S; Baba S
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():284-8. PubMed ID: 12599586
    [No Abstract]   [Full Text] [Related]  

  • 19. Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility?
    van der Kwast TH
    Eur Urol; 2006 Feb; 49(2):209-11. PubMed ID: 16417961
    [No Abstract]   [Full Text] [Related]  

  • 20. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.